Clinical Trial Update: Pilot Study of Expanded , Activated Haploidentical Natural Killer Cell Infusions for Sarcomas [Phase 1, Phase 2]

View source ↗

Summary

Pilot study investigating expanded, activated haploidentical natural killer cell infusions for Ewing sarcoma and rhabdomyosarcoma across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma
• Rhabdomyosarcoma

Drugs mentioned

• haploidentical natural killer cell infusions (natural killer cell infusion)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Ewing Sarcoma, Rhabdomyosarcoma | Phase 1, Phase 2 | Status: UNKNOWN